JP2015509504A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509504A5 JP2015509504A5 JP2014558892A JP2014558892A JP2015509504A5 JP 2015509504 A5 JP2015509504 A5 JP 2015509504A5 JP 2014558892 A JP2014558892 A JP 2014558892A JP 2014558892 A JP2014558892 A JP 2014558892A JP 2015509504 A5 JP2015509504 A5 JP 2015509504A5
- Authority
- JP
- Japan
- Prior art keywords
- arg
- phe
- dmt
- lys
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261602418P | 2012-02-23 | 2012-02-23 | |
| US61/602,418 | 2012-02-23 | ||
| PCT/US2013/027430 WO2013126775A1 (en) | 2012-02-23 | 2013-02-22 | Aromatic-cationic peptides and uses of same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017235950A Division JP2018076337A (ja) | 2012-02-23 | 2017-12-08 | 芳香族陽イオン性ペプチドおよびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015509504A JP2015509504A (ja) | 2015-03-30 |
| JP2015509504A5 true JP2015509504A5 (enExample) | 2016-04-14 |
Family
ID=49006261
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558892A Pending JP2015509504A (ja) | 2012-02-23 | 2013-02-22 | 芳香族陽イオン性ペプチドおよびその使用 |
| JP2017235950A Pending JP2018076337A (ja) | 2012-02-23 | 2017-12-08 | 芳香族陽イオン性ペプチドおよびその使用 |
| JP2019210301A Pending JP2020059720A (ja) | 2012-02-23 | 2019-11-21 | 芳香族陽イオン性ペプチドおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017235950A Pending JP2018076337A (ja) | 2012-02-23 | 2017-12-08 | 芳香族陽イオン性ペプチドおよびその使用 |
| JP2019210301A Pending JP2020059720A (ja) | 2012-02-23 | 2019-11-21 | 芳香族陽イオン性ペプチドおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10808008B2 (enExample) |
| EP (2) | EP2817021B1 (enExample) |
| JP (3) | JP2015509504A (enExample) |
| CN (1) | CN104203262A (enExample) |
| AU (3) | AU2013222237B2 (enExample) |
| CA (1) | CA2865409C (enExample) |
| WO (1) | WO2013126775A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105753939A (zh) * | 2012-04-12 | 2016-07-13 | 康德生物医疗技术公司 | 芳香族阳离子肽及其用途 |
| ES2755134T3 (es) * | 2013-03-01 | 2020-04-21 | Stealth Biotherapeutics Corp | Métodos para el tratamiento de enfermedad mitocondrial |
| US9687519B2 (en) | 2013-03-01 | 2017-06-27 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention or treatment of barth syndrome |
| CA2916977A1 (en) | 2013-06-26 | 2014-12-31 | Stealth Biotherapeutics Corp | Methods and compositions for detecting and diagnosing diseases and conditions |
| JP2016540762A (ja) * | 2013-12-02 | 2016-12-28 | ステルス バイオセラピューティックス コープ | 白斑の治療のための組成物及び方法 |
| DE102015207415A1 (de) | 2015-04-23 | 2016-10-27 | Adidas Ag | Verfahren und Gerät zum Verknüpfen von Bildern in einem Video einer Aktivität einer Person mit einem Ereignis |
| CN109069572A (zh) * | 2015-12-31 | 2018-12-21 | 康德生物医疗技术公司 | 包含肽的治疗性组合物和其用途 |
| WO2017180535A1 (en) | 2016-04-11 | 2017-10-19 | Carnot, Llc | Chiral peptides |
| CN107320711A (zh) * | 2017-03-24 | 2017-11-07 | 南京大学 | 化合物ss‑31在制备治疗弗里德赖希共济失调及相关疾病药物中的应用 |
| CN107041946A (zh) * | 2017-03-24 | 2017-08-15 | 南京大学 | 化合物ss‑31在制备治疗动脉粥样硬化及相关疾病药物或制剂上的应用 |
| IL284006B2 (en) * | 2018-12-18 | 2024-12-01 | Stealth Biotherapeutics Corp | Mitochondria-targeting peptides |
| CN115400201A (zh) * | 2021-05-26 | 2022-11-29 | 四川大学华西医院 | Ss-31在制备预防和/或治疗香烟诱导的气道炎症及慢性阻塞性肺疾病的药物中的用途 |
| CN117881411A (zh) | 2021-06-01 | 2024-04-12 | 艾迪雅生物有限责任公司 | 用于眼部药物的延长释放药物递送系统和使用方法 |
| WO2025121297A1 (ja) * | 2023-12-08 | 2025-06-12 | サントリーホールディングス株式会社 | エネルギー代謝促進用組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| CA3024434A1 (en) * | 2004-01-23 | 2005-08-11 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| AU2005287004B2 (en) * | 2004-09-16 | 2011-03-17 | The Regents Of The University Of California | G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| AU2006325030B2 (en) | 2005-12-16 | 2012-07-26 | Cellectis | Cell penetrating peptide conjugates for delivering nucleic acids into cells |
| EP3741381B1 (en) * | 2008-02-26 | 2024-04-24 | Cornell University | A peptide for use for prevention and treatment of acute renal injury |
| HK1201443A1 (en) * | 2011-10-17 | 2015-09-04 | Cornell University | Aromatic-cationic peptides and uses of same |
-
2013
- 2013-02-22 CN CN201380016624.6A patent/CN104203262A/zh active Pending
- 2013-02-22 JP JP2014558892A patent/JP2015509504A/ja active Pending
- 2013-02-22 AU AU2013222237A patent/AU2013222237B2/en active Active
- 2013-02-22 EP EP13751525.0A patent/EP2817021B1/en active Active
- 2013-02-22 EP EP18207640.6A patent/EP3513800B1/en active Active
- 2013-02-22 US US14/380,484 patent/US10808008B2/en active Active
- 2013-02-22 CA CA2865409A patent/CA2865409C/en active Active
- 2013-02-22 WO PCT/US2013/027430 patent/WO2013126775A1/en not_active Ceased
-
2017
- 2017-12-08 JP JP2017235950A patent/JP2018076337A/ja active Pending
-
2018
- 2018-01-02 AU AU2018200000A patent/AU2018200000A1/en not_active Abandoned
-
2019
- 2019-09-17 AU AU2019232783A patent/AU2019232783B2/en active Active
- 2019-11-21 JP JP2019210301A patent/JP2020059720A/ja active Pending
-
2020
- 2020-10-07 US US17/064,937 patent/US20210261613A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509504A5 (enExample) | ||
| JP2024075713A5 (enExample) | ||
| JP7548669B2 (ja) | 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物 | |
| ES2941640T3 (es) | Moduladores de la actividad del complemento | |
| JP2020517719A (ja) | 睡眠時無呼吸を治療する方法及び組成物 | |
| JP2013535437A5 (enExample) | ||
| JP2008044951A5 (enExample) | ||
| CA2923685A1 (en) | Application of r-ketamine and salt thereof as pharmaceuticals | |
| JP2007514750A5 (enExample) | ||
| CN1481256A (zh) | 一氧化氮的吸入 | |
| AU2018260883A1 (en) | Treatment of central nervous system disorders by intranasal administration of immunoglobulin g | |
| JP2007506752A (ja) | 肺動脈高血圧症を治療するための併用療法におけるイロプロスト | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| JP2025510916A5 (enExample) | ||
| JP2021518381A5 (enExample) | ||
| WO2009099642A3 (en) | Proteomic analysis of active multiple sclerosis lesions | |
| Cho et al. | Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery | |
| JP2005532321A (ja) | 呼吸器の疾患および状態の、選択的ｉＮＯＳ阻害剤とＰＤＥ阻害剤による治療方法、ならびにそのための組成物 | |
| JP2021520396A5 (enExample) | ||
| CA2314173C (fr) | Utilisations therapeutiques de melanges gazeux d'helium et d'oxygene, en particulier dans le traitement de l'asthme | |
| JP2023538419A5 (enExample) | ||
| JP2003040797A (ja) | 抗炎症性肺疾患およびａｒｄｓにおける抗トロンビン吸入のための医薬製剤 | |
| RU2009141168A (ru) | Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна | |
| JP2005533062A (ja) | キセノン含有ガスによる脳保護 | |
| JP2021511352A5 (enExample) |